(cont. news of NAVANAPHAR): Mrs. Saiqa Mazed-Chairman and Independent Director, Professor Dr. Md. Jonaid Shafiq-Managing Director, Dr. Sayeed Ahmed-Director, Mr. Javed Kaiser Ally-Director, Mrs. Tarana Ahmed-Director, Mrs. Masuma Parvin-Director, Mr. Khondaker Sabbir Mohammad Kabir (Nominee of Stratus Holdings Limited)-Director, Mr. Mohammad Arife Billah (Bar-At-Law)-Independent Director, Professor Mohammad Shofiqul Islam-Independent Director. (end)

The company has informed that pursuant to the direction of the Bangladesh Securities and Exchange Commission reference no: BSEC/ICSD/SRIC/2026-313/part-03/123: dated June 18, 2026, the 64th Meetings of the Board of Directors of Navana Pharmaceuticals PLC. have been postponed, with a direction to maintain the composition of the Board as it stood at the 63rd Board Meeting. Accordingly, as per the 63rd Board Meeting, the current members of the Board of Directors are as follows: (cont.)

Dhaka Stock Exchange PLC. (DSE) has approved the transfer of 16,04,603 shares of Navana Pharmaceuticals PLC held by Mr. Manzurul Islam (Sponsor), transferor, to Dr. Md. Jonaid Shafiq (Managing Director), transferee, within next 30 working days with effect from August 02, 2026 outside the trading system of the Exchange other than by way of gift under Regulation 47(1)(b) of the Dhaka Stock Exchange (Listing) Regulations, 2015 as well as other applicable laws.

(Cont. news of NAVANAPHAR): 2. The Company has decided to proceed with a Foreign Loan Facilities for EUR 26,610,000.00 for 12 years from AKA Ausfuhrkredit-Gesellschaft mbH, Frankfurt, Germany, the sole arranger of which is KGMC Financial Service, Bangladesh. The Company has decided to avail the aforesaid facilities for expansion of its production facilities. The proposed financing shall remain subject to final approval from the concerned regulatory authorities & completion of due diligence. (end)

(Cont. news of NAVANAPHAR): Reasons for significant deviation in EPS and NOCFPS: Increment of Earnings per Share in the reporting period by 31.52% because of growth of Sales Revenue as well as optimum cost management policy & Net Operating Cash Flow per Share (NOCFPS) has increased to Tk. 15.44 from Tk. 10.22, due to cash received from the customers was higher than the cash payment for operation in the reporting period. (cont.2)